What Gene Mutations Matter in CLL
Researchers are discovering new genetic mutations in cancer cells at an ever more rapid pace. Some of these discoveries have immediate significance for a CLL patient's prognosis and treatment strategy while the significance of some other mutations is less clear. Renowned CLL expert, Dr. Stefan Stilgenbauer explains which of these genetic mutations are significant now and discusses why. He also explains how exciting, investigational treatments could vastly improve outcomes and reduce side effects for a broad group of CLL patients.
Experts & Guests
Stephan Stilgenbauer, M.D.
Associate Professor at the Department of Haematology, Oncology, Rheumatology and Infectious Diseases, University of UlmDr. Stephan Stilgenbauer is Associate Professor in the Department of Hematology, Oncology, Rheumatology and Infectious Diseases at the University of Ulm, Germany. He received his medical training at Ruprecht-Karls Universität Heidelberg Medical School, Germany with electives in Hamilton, Canada; Jerusalem, Israel; Bath, UK and Cambridge, UK. He went on to complete his final year at the Baylor College of Medicine... more >